Zhitong Financial App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, the company received the approval and issuance of metformin englicin tablets (I) “drug registration certificate” from the State Drug Administration. Metformin englicin tablets (I) are combined with diet control and exercise, and are suitable for adult patients with type 2 diabetes who are being treated with englizin and metformin hydrochloride to improve blood sugar control in these patients. The company's metformin englicin tablets (I) obtained a drug registration certificate according to the new registration classification of 4 types of chemicals, which is deemed to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.